RV
RVL Pharmaceuticals plc
RVLPQ · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.11K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 23.63%
Rev. growth 40.83%
FCF growth N/A
Profitability
20 /100
Weak Net margin 103.96%
Op. margin 91.87%
FCF margin 77.56%
Quality
7 /100
Poor ROA 40.22%
Asset turnover 0.39x
ROIC 41.26%
Debt
64 /100
Moderate Current ratio 2.89x
Int. coverage -15.63x
Net debt/EBITDA -0.36x
Stability
22 /100
Unstable Rev. volatility 144.80%
EPS volatility 28.09%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RVLPQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Brian A. Markison
Employees
125
Headquarters
Bridgewater
Upcoming events
13 NOV
Earnings
Upcoming earnings report